Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

824
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
824
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

661
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
661
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

772
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
772
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

732
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
732
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

841
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
841
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

463
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
463

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recovery Experiences of Older Adults and Their Caregivers After Major Elective Noncardiac Surgery.

JAMA network open·2026
Same author

Helping trainees grow by nurturing mindset, motivation, and grit: a developmental framework for medical education.

Academic medicine : journal of the Association of American Medical Colleges·2026
Same author

Variables impacting the likelihood of successful remediation during residency training.

Medical teacher·2026
Same author

Toward integrated risk management of patient falls and patient-assisted injuries: four indicators to support a joint approach.

International journal for quality in health care : journal of the International Society for Quality in Health Care·2025
Same author

Significant new disability after major non-cardiac surgery in older adults aged 65 years and older in Canada: a multicentre prospective cohort study.

The lancet. Healthy longevity·2025
Same author

Successful Vaginal Birth in Severe Idiopathic Pulmonary Arterial Hypertension: Lessons Learned From a Cardio-Obstetric Challenge.

JACC. Case reports·2025

Related Experiment Video

Updated: Apr 5, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

18.1K

Peripartum cardiomyopathy: current knowledge and future directions.

Melinda Davis1, Claire Duvernoy1

  • 1Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, 1500 E Medical Center Drive, SPC 5853, Ann Arbor, MI 48109-5853, USA.

Women'S Health (London, England)
|August 7, 2015
PubMed
Summary

Peripartum cardiomyopathy is a serious heart failure condition during late pregnancy or postpartum. Early diagnosis and adjusted treatment are crucial for maternal health, though risks remain with future pregnancies.

Keywords:
peripartum cardiomyopathypostpartum cardiomyopathypregnancy-associated cardiomyopathy

More Related Videos

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

8.1K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K

Related Experiment Videos

Last Updated: Apr 5, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
14:39

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples

Published on: April 21, 2014

18.1K
Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

8.1K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K

Area of Science:

  • Cardiology
  • Maternal-Fetal Medicine
  • Heart Failure Research

Background:

  • Peripartum cardiomyopathy (PPCM) is a rare form of heart failure.
  • It occurs late in pregnancy or postpartum, posing risks of recovery, persistent dysfunction, or death.
  • Certain demographics like African-American women, older age, hypertension, and multiple gestations increase risk.

Purpose of the Study:

  • To summarize the key aspects of peripartum cardiomyopathy.
  • To highlight diagnostic challenges and essential tools.
  • To discuss management considerations during and after pregnancy.

Main Methods:

  • Review of existing literature on peripartum cardiomyopathy.
  • Emphasis on diagnostic criteria and imaging techniques.
  • Discussion of current treatment strategies and their modifications.

Main Results:

  • Diagnosis can be delayed due to overlapping symptoms with normal pregnancy.
  • Echocardiography is vital for diagnosis; B-type natriuretic peptide aids assessment.
  • Treatment requires careful adjustment for pregnant patients, with potential need for anticoagulation.

Conclusions:

  • Peripartum cardiomyopathy necessitates prompt diagnosis and tailored management.
  • Subsequent pregnancies carry significant risks even after initial recovery.
  • Further research is needed on etiology, optimal treatment duration, and relapse risks.